Dr. Perlmutter's BrainSustain

Develop. Enhance. Preserve.

 

Nutritional Support for Enhancing Brain Function, Maintaining Memory, and Protecting the Brain

BrainSustain was developed by David Perlmutter, MD, FACN, Board-Certified Neurologist and internationally recognized leader in nutritional neurology. This product is the result of over 30 years of research in the clinical neurosciences. Ingredients used in this formula have been evaluated in extensive clinical studies and have been shown to enhance brain function, maintain memory, and protect the brain from the effects of free radicals.

BrainSustain's unique formula enhances brain performance and promotes brain health by improving the energy production of brain mitochondria. It facilitates neural communication, and provides superior antioxidant action that reduces the production and damaging effects of excess free radicals in the brain. This antioxidant action is vital because excess free radicals are associated with brain inflammation – a marker and common thread among such neurodegenerative disorders as poor memory, Alzheimer’s disease, Parkinson’s disease, multiple sclerosis, ALS, and others.

Taking BrainSustain is an easy, daily good health habit. Our powder formulas mix with fruit juice or smoothies to become a refreshing and profoundly beneficial beverage – providing the highest level of brain performance enhancing nutrients and powerful brain protection to ensure long term optimal brain performance throughout your life. BrainSustain’s key ingredients have been extensively studied for efficacy at some of the world’s most well respected medical institutions.7-17

BrainSustain is a key part of a complete program to ensure optimal brain function. A healthy diet, physical exercise and mental activity all contribute to achieving and maintaining peak mental performance.

References

  1. Schults, C.W., Beal, M.F., Fontaine, K., et al. Absorption, tolerability and effects on mitochondrial activity of oral coenzyme Q10 in parkinsonsian patients, Neurology 50: 793-795, 1998. [ Back ^ ]
  2. Marangon, K., Deveraj, S., Tirosh, O., et al., Comparison of the effect of a-lipoic acid and a-tocopherol supplementation on measures of oxidative stress. Free Radical Biology and Medicine 27(9/10): 1114-1121, 1999. [ Back ^ ]
  3. Pahan, K., Sheikh, G.S., Nmboodri, A.M.S., et al., N-acetyl cysteine inhibits induction of NO production by endotoxin or cytokine stimulated rat peri-toneal macrophages, C6 glial cells and astrocytes. Free Radical Biology and Medicine 24(1):39-48, 1998. [ Back ^ ]
  4. Steffen V. Santiago, M., de la Cruz, C.P., et al., Effect of intraventricular injection of 1-methyl-4-phenylpridinium protection by acetyl-L-carnitine. Human Exp Toxicol 14:865-871, 1995. [ Back ^ ]
  5. Thal L.J., Carta A. Clarke, W.R., et al., A 1-year multicenter placebo-con-trolled study of acetyl-L-carnitine in patients with Alzheimer's disease. Neurology 47:705-711, 1996. [ Back ^ ]
  6. Sano, M., Ernesto, C., Thomas, R.G., et al., A controlled trial of selegeline, alpha-tocopherol, or both as treatment for Alzheimer's disease. N England J Med 336:1216-22, 1997. [ Back ^ ]
  7. Golbe, L.I., Farrell, T.M., David, P.H., Case-control study of early life dietary factors in Parkinson's disease. Arch Neurol 45(12): 1350-3, 1988. [ Back ^ ]
  8. Fahn, S., The endogenous toxin theory of the etiology of Parkinson's dis-ease and a pilot trial of high-dose antioxidants in an attempt to slow the progression of the illness. Ann N Y Acad Sci 570:186-96, 1989. [ Back ^ ]
  9. Le Bars, P., Katz, M.M., Berman, N., et al,. a Placebo-Controlled, Double-blind Randomized Trial of an Extract of Gingko Biloba for Dementia. JAMA 278(16): 1327-32, 1997. [ Back ^ ]
  10. Sardar, S., Chakraborty, A., and Chatterjee, M., Comparative effectiveness of vitamin D3 and dietary vitamin E on peroxidation of lipids and enzymes of the hepatic antioxidant system in Sprague-Dawley rats. Int J Vitam Nutr Res, 66(1):39-45, 1996. [ Back ^ ]
  11. Crook, T.H., Tinklenberg, J., Yesavage, J., Effects of phosphatidylserine in age-associated memory impairment. Neurology 41:644-49, 1991. [ Back ^ ]